TECENTRIQ

UNIISPLATC L01FF05

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerGenentech, Inc.

CountryUS (United States)

ATC codeL01FF05

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 2

ndc11
5024291701
1 VIAL, SINGLE-USE in 1 CARTON (50242-917-01) / 20 mL in 1 VIAL, SINGLE-USE
ndc11
5024291786
1 VIAL, SINGLE-USE in 1 CARTON (50242-917-86) / 20 mL in 1 VIAL, SINGLE-USE

Annotations

UNII (FDA Substance ID)

52CMI0WC3Y

ATEZOLIZUMAB

RxCUI 1792776

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "52CMI0WC3Y",
    "rxcui": "1792776",
    "inchikey": null,
    "display_name": "ATEZOLIZUMAB",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "a617b089-ce66-464b-987b-b45d029b4d6f": {
      "match": "brand_token",
      "title": "TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) INJECTION [GENENTECH, INC.]",
      "spl_version": "7",
      "published_date": "2026-05-28"
    }
  },
  "productid": "50242-917_4b922b35-c401-4189-a8b2-9f9a820878db",
  "productndc": "50242-917",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ATEZOLIZUMAB",
  "proprietary_name": "TECENTRIQ",
  "active_ingred_unit": "mg/20mL",
  "application_number": "BLA761034",
  "marketing_category": "BLA",
  "nonproprietary_name": "atezolizumab",
  "start_marketing_date": "20160518",
  "active_numerator_strength": "1200"
}

Related drugs

Other records sharing ATC code L01FF05.

Access this data programmatically

Query TECENTRIQ and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs